Literature DB >> 8258768

Nonlinear mixed effect modeling of the pharmacodynamics of natriuretic peptides in rats.

Y Hashimoto1, S Mori, N Hama, K Nakao, H Imura, M Yamaguchi, M Yasuhara, R Hori.   

Abstract

Natriuretic peptides have not only natriuretic/diuretic but also hypotensive activities, and the decreased renal perfusion caused by the excessive hypotension is known to attenuate the diuretic actions. The present study was designed to examine the relationship between the dosing (intravenous constant infusion) rates and the diuretic actions of alpha-rat atrial natriuretic peptide (alpha-rANP) and rat brain natriuretic peptide (rBNP) in rats, and population (nonlinear mixed effect model) analysis was applied to these complicated diuretic actions. The intrinsic diuretic activities of alpha-rANP and rBNP could be analyzed, and the effects of blood pressure, heart rate, and also inhibition of degradation enzyme on the diuresis of natriuretic peptides were estimated simultaneously. The population analysis was useful for analyzing such pharmacodynamic data for which the individual analysis could not be applied easily.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258768     DOI: 10.1007/bf01059780

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  26 in total

1.  Rat brain natriuretic peptide--tissue distribution and molecular form.

Authors:  Y Ogawa; K Nakao; M Mukoyama; G Shirakami; H Itoh; K Hosoda; Y Saito; H Arai; S Suga; M Jougasaki
Journal:  Endocrinology       Date:  1990-04       Impact factor: 4.736

Review 2.  Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide.

Authors:  A J Kenny; S L Stephenson
Journal:  FEBS Lett       Date:  1988-05-09       Impact factor: 4.124

3.  Degradation of atrial natriuretic peptide: pharmacologic effects of protease EC 24.11 inhibition.

Authors:  R L Webb; G D Yasay; C McMartin; R B McNeal; M B Zimmerman
Journal:  J Cardiovasc Pharmacol       Date:  1989-08       Impact factor: 3.105

4.  Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure.

Authors:  M R Wilkins; S L Settle; P T Stockmann; P Needleman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

5.  A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor.

Authors:  M Chinkers; D L Garbers; M S Chang; D G Lowe; H M Chin; D V Goeddel; S Schulz
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

6.  Clearance of brain natriuretic peptide in patients with chronic heart failure: indirect evidence for a neutral endopeptidase mechanism but against an atrial natriuretic peptide clearance receptor mechanism.

Authors:  C C Lang; J G Motwani; W J Coutie; A D Struthers
Journal:  Clin Sci (Lond)       Date:  1992-06       Impact factor: 6.124

7.  Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.

Authors:  M Yoshimura; H Yasue; E Morita; N Sakaino; M Jougasaki; M Kurose; M Mukoyama; Y Saito; K Nakao; H Imura
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

8.  Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.

Authors:  S Suga; K Nakao; K Hosoda; M Mukoyama; Y Ogawa; G Shirakami; H Arai; Y Saito; Y Kambayashi; K Inouye
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

9.  Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo.

Authors:  G M Olins; P A Krieter; A J Trapani; K L Spear; P R Bovy
Journal:  Mol Cell Endocrinol       Date:  1989-02       Impact factor: 4.102

10.  Prolonged hemodynamic benefits from a high-dose bolus injection of human atrial natriuretic factor in congestive heart failure.

Authors:  T D Giles; A C Quiroz; L E Roffidal; H Marder; G E Sander
Journal:  Clin Pharmacol Ther       Date:  1991-11       Impact factor: 6.875

View more
  4 in total

1.  Nonlinearity detection: advantages of nonlinear mixed-effects modeling.

Authors:  E N Jonsson; J R Wade; M O Karlsson
Journal:  AAPS PharmSci       Date:  2000

2.  Effect of neutral endopeptidase inhibition on the natriuresis and renal clearance of atrial natriuretic peptide in perfused rat kidney.

Authors:  M Yamaguchi; Y Hashimoto; H Itoh; K Nakao; K Inui
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

3.  Simulation for the analysis of distorted pharmacodynamic data.

Authors:  Y Hashimoto; J Ozaki; T Koue; A Odani; M Yasuhara; R Hori
Journal:  Pharm Res       Date:  1994-04       Impact factor: 4.200

4.  Natriuretic peptide-potentiating actions of neutral endopeptidase inhibition in rats with experimental heart failure.

Authors:  M Yasuhara; M Yamaguchi; H Shimizu; Y Hashimoto; N Hama; H Itoh; K Nakao; R Hori
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.